Latest & greatest articles for tamsulosin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tamsulosin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tamsulosin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tamsulosin

21. Jalyn (dutasteride 0.5 mg/tamsulosin hydrochloride 0.4 mg)

Jalyn (dutasteride 0.5 mg/tamsulosin hydrochloride 0.4 mg) Drug Approval Package: Jalyn (dutasteride and tamsulosin) NDA #022460 Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Jalyn (dutasteride 0.5 mg/tamsulosin hydrochloride 0.4 mg) Company: GlaxoSmithKline LLC Application No.: 022460 Approval Date: 06/14/2010 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF) (PDF

FDA - Drug Approval Package2010

22. Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review Dong Z, Wang Z, Yang K, Liu Y, Gao W, Chen W CRD summary The authors concluded that tamsulosin improved International Prostate Symptom Score in the short-term compared to terazosin. High-quality trials were needed to assess the efficacy of tamsulosin (...) in the long term. Some review limitations made the reliability of the pooled results uncertain, but the overall conclusion was suitably cautious and appears appropriate. Authors' objectives To assess the safety and efficacy of tamsulosin compared to terazosin in patients with benign prostate hyperplasia. Searching PUBMED, EMBASE, The Cochrane Library (2007 Issue 4), Chinese Biomedical Literature Database and CMKI were searched to 2007 for published papers; search terms were not reported. Reference lists

DARE.2009

23. Off-label Use Tamsulosin in the Presence of Uncomplicated Radiographically Proven Distal Urolithiasis

Off-label Use Tamsulosin in the Presence of Uncomplicated Radiographically Proven Distal Urolithiasis "Off-label Use Tamsulosin in the Presence of Uncomplicated Radiographic" by Winslow Lewis < > > > > > Title Author Date of Award 8-15-2009 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Anya Hill Second Advisor Rob Rosenow PharmD, OD Third Advisor Annjanette Sommers MS, PA-C Rights . Abstract Background: The impact that distal (...) by which voiding occurs decreasing the intra-luminal pressure. Likewise, the alpha 1 receptors present in the distal ureter have similar implications to that of the prostate in terms of ureteral relaxation, theoretically increasing the possibility for stone expulsion and reducing renal colic caused by the increased peristaltic movement in the presence of a kidney stone. Hypothesis: The administration of the off-label use of tamsulosin with traditional conservative urolithiasis therapy will increase

Pacific University EBM Capstone Project2009

24. Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi

Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi Losek RL, Mauro LS CRD summary This review concluded that tamsulosin adjunctive to extracorporeal shock wave lithotripsy was safe and effective in treating patients with renal (...) stones of 10 to 24mm diameter; evidence was inconclusive for ureteral stone clearance. Given the poor reporting of the review process and lack of adequate primary trial information, the authors' conclusions should be treated with caution. Authors' objectives To evaluate the safety and efficacy of tamsulosin as an adjunct to extracorporeal shock wave lithotripsy (ESWL) in improving renal and ureteral stone clearance Searching MEDLINE(1950 to January 2008) and Iowa Drug Information System (1966 to January

DARE.2008

26. Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage.

Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage. BestBets: Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage. Use of tamsulosin in patients with urinary calculi to increase spontaneous stone passage. Report By: Brook Woolley, M.D. - Emergency Medicine Resident Search checked by Jeffrey Jones MD - Research Director Institution: Grand Rapids Medical Education & Research/Michigan State University Date Submitted: 21st (...) May 2007 Date Completed: 28th September 2007 Last Modified: 5th June 2007 Status: Green (complete) Three Part Question In [patients presenting to the Emergency Department with urinary calculi] does [tamsulosin (Flomax)] compared to conservative therapy [increase the rate of spontaneous stone passage]? Clinical Scenario A patient presents to the Emergency Department with a 6 mm calculi in the left distal ureter. You wonder if the use of tamsulosin would improve the chances of spontaneous stone

BestBETS2007

27. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. 17105794 2006 11 19 2006 11 22 2016 10 17 1538-3598 296 19 2006 Nov 15 JAMA JAMA Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. 2319-28 Men with overactive bladder and other lower urinary tract symptoms may not respond to monotherapy with antimuscarinic agents or alpha (...) -receptor antagonists. To evaluate the efficacy and safety of tolterodine extended release (ER), tamsulosin, or both in men who met research criteria for both overactive bladder and benign prostatic hyperplasia. Randomized, double-blind, placebo-controlled trial conducted at 95 urology clinics in the United States involving men 40 years or older who had a total International Prostate Symptom Score of 12 or higher and, an International Prostate Symptom Score quality-of-life (QOL) item score of 3

JAMA2006